Document is current

Any future updates will be listed below

Correction to: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer

Crossref DOI link: https://doi.org/10.1186/s12957-025-03831-0

Published Online: 2025-05-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark